BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 32609299)

  • 1. SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration.
    Ko KW; Milbrandt J; DiAntonio A
    J Cell Biol; 2020 Aug; 219(8):. PubMed ID: 32609299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD
    Sasaki Y; Nakagawa T; Mao X; DiAntonio A; Milbrandt J
    Elife; 2016 Oct; 5():. PubMed ID: 27735788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons.
    Sasaki Y; Engber TM; Hughes RO; Figley MD; Wu T; Bosanac T; Devraj R; Milbrandt J; Krauss R; DiAntonio A
    Exp Neurol; 2020 Jul; 329():113252. PubMed ID: 32087251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAPK signaling promotes axonal degeneration by speeding the turnover of the axonal maintenance factor NMNAT2.
    Walker LJ; Summers DW; Sasaki Y; Brace EJ; Milbrandt J; DiAntonio A
    Elife; 2017 Jan; 6():. PubMed ID: 28095293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of SARM1 rescues development and survival of NMNAT2-deficient axons.
    Gilley J; Orsomando G; Nascimento-Ferreira I; Coleman MP
    Cell Rep; 2015 Mar; 10(12):1974-81. PubMed ID: 25818290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury.
    Fernandes KA; Mitchell KL; Patel A; Marola OJ; Shrager P; Zack DJ; Libby RT; Welsbie DS
    Exp Eye Res; 2018 Jun; 171():54-61. PubMed ID: 29526794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DLK Activation Synergizes with Mitochondrial Dysfunction to Downregulate Axon Survival Factors and Promote SARM1-Dependent Axon Degeneration.
    Summers DW; Frey E; Walker LJ; Milbrandt J; DiAntonio A
    Mol Neurobiol; 2020 Feb; 57(2):1146-1158. PubMed ID: 31696428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotoxins subvert the allosteric activation mechanism of SARM1 to induce neuronal loss.
    Wu T; Zhu J; Strickland A; Ko KW; Sasaki Y; Dingwall CB; Yamada Y; Figley MD; Mao X; Neiner A; Bloom AJ; DiAntonio A; Milbrandt J
    Cell Rep; 2021 Oct; 37(3):109872. PubMed ID: 34686345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARM1 is a metabolic sensor activated by an increased NMN/NAD
    Figley MD; Gu W; Nanson JD; Shi Y; Sasaki Y; Cunnea K; Malde AK; Jia X; Luo Z; Saikot FK; Mosaiab T; Masic V; Holt S; Hartley-Tassell L; McGuinness HY; Manik MK; Bosanac T; Landsberg MJ; Kerry PS; Mobli M; Hughes RO; Milbrandt J; Kobe B; DiAntonio A; Ve T
    Neuron; 2021 Apr; 109(7):1118-1136.e11. PubMed ID: 33657413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration.
    Loreto A; Hill CS; Hewitt VL; Orsomando G; Angeletti C; Gilley J; Lucci C; Sanchez-Martinez A; Whitworth AJ; Conforti L; Dajas-Bailador F; Coleman MP
    Neurobiol Dis; 2020 Feb; 134():104678. PubMed ID: 31740269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program.
    Geisler S; Doan RA; Cheng GC; Cetinkaya-Fisgin A; Huang SX; Höke A; Milbrandt J; DiAntonio A
    JCI Insight; 2019 Sep; 4(17):. PubMed ID: 31484833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage depletion blocks congenital SARM1-dependent neuropathy.
    Dingwall CB; Strickland A; Yum SW; Yim AK; Zhu J; Wang PL; Yamada Y; Schmidt RE; Sasaki Y; Bloom AJ; DiAntonio A; Milbrandt J
    J Clin Invest; 2022 Dec; 132(23):. PubMed ID: 36287209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARM1 activation triggers axon degeneration locally via NAD⁺ destruction.
    Gerdts J; Brace EJ; Sasaki Y; DiAntonio A; Milbrandt J
    Science; 2015 Apr; 348(6233):453-7. PubMed ID: 25908823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palmitoylation enables MAPK-dependent proteostasis of axon survival factors.
    Summers DW; Milbrandt J; DiAntonio A
    Proc Natl Acad Sci U S A; 2018 Sep; 115(37):E8746-E8754. PubMed ID: 30150401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitophagy suppresses motor neuron necroptotic mitochondrial damage and alleviates necroptosis that converges to SARM1 in acrylamide-induced dying-back neuropathy.
    Wang S; Yang Y; Yu Z; Song M; Liu Z; Shan S; Yong H; Ni W; Qiang Y; Zhang C; Wang S; Zhao X; Song F
    J Neurochem; 2023 Aug; 166(3):588-608. PubMed ID: 37350308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial dysfunction induces Sarm1-dependent cell death in sensory neurons.
    Summers DW; DiAntonio A; Milbrandt J
    J Neurosci; 2014 Jul; 34(28):9338-50. PubMed ID: 25009267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARM1 depletion rescues NMNAT1-dependent photoreceptor cell death and retinal degeneration.
    Sasaki Y; Kakita H; Kubota S; Sene A; Lee TJ; Ban N; Dong Z; Lin JB; Boye SL; DiAntonio A; Boye SE; Apte RS; Milbrandt J
    Elife; 2020 Oct; 9():. PubMed ID: 33107823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism.
    Gerdts J; Summers DW; Milbrandt J; DiAntonio A
    Neuron; 2016 Feb; 89(3):449-60. PubMed ID: 26844829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemical biology of NAD
    Icso JD; Thompson PR
    Curr Opin Chem Biol; 2022 Aug; 69():102176. PubMed ID: 35780654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease.
    Peters OM; Weiss A; Metterville J; Song L; Logan R; Smith GA; Schwarzschild MA; Mueller C; Brown RH; Freeman M
    Neurobiol Dis; 2021 Jul; 155():105368. PubMed ID: 33892050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.